4 for the diagnosis of BKVAN were as follows: sensitivity, 100%; specificity, 99.1%; NPV, 100%; PPV, 59.4%. Specificity and PPV rose to 99.6% and 75.0% when using a cut-off level of 1.6 × 10 4 copies/mL. Conclusions. The recommended level of BK viraemia of 10 4 copies/mL is useful to identify patients at risk of BKVAN, although specificity and PPV increase by using a cut-off level of 1.6 × 10 4 copies/mL. BK replication may occur in the first 3 months post-transplantation and subsequently recede. Therefore, the temporal profile of BKV replication has to be accurately evaluated and occasionally elevated values should prompt a closer monitoring.
Introduction
Human polyomavirus BK (BKV) is a worldwidedistributed virus the seroprevalence rate of which is ∼70-90% in adults. Following primary infection, BK remains latent in the renourinary tract as the epidemiologically most relevant latency site, and in B cell, brain, spleen and probably other tissues. Reactivation with asymptomatic viruria may occur in both immunocompetent subjects and immunocompromised patients. In renal transplantation, in the context of intense immunosuppression, viral replication may determine BKV-associated nephropathy (BKVAN) with interstitial nephritis and/or ureteral stenosis in 1-10% of the patients, particularly in the first year following transplantation, and leading to graft failure and return to haemodialysis in 30 to 80% of the cases [1] [2] [3] . Today, BKVAN is one of the most common viral diseases affecting renal allografts. Screening for polyomavirus replication may allow for earlier intervention with reduced allograft loss [2] . A presumed diagnosis of BKVAN may be made in the presence of surrogate markers of viral replication, such as plasma viral load >10 4 copies/mL of BKV DNA [2] . Thus, screening for BKV replication represents the basic strategy to predict early the onset of BKVAN [2, 3] . The aim of this study was to investigate the operating characteristics of BKV replication monitoring for the development of BKVAN in renal transplant recipients in the first year post-transplantation.
Materials and methods

Patients and samples
Two hundred twenty-nine renal transplant recipients (140 males, 89 females; mean age ± standard deviation, 53.2 ± 14. Thirty healthy subjects, including health care workers in the Nephrology Ward (8 subjects) or in the Virology Unit (4 subjects), and 50 non-transplant patients with lupus nephritis (14 not treated and 36 treated with steroids or immunosuppressive agents, as described elsewhere [4] ) were also evaluated.
PCR for BKV-DNA quantification in serum and urine samples
Extraction procedure from serum and urine samples was performed as previously described [5] . BKV-DNA quantification was performed by Real-Time TaqMan PCR using a commercial kit (BKV Q-PCR Alert Kit; Nanogen Advanced Diagnostic, Milano, Italy) for the detection of the target viral gene encoding for the large T-antigen of BKV with the 7300 Real-Time PCR System (Applied Biosystems, Foster City, CA, USA). According to the manufacturer's instructions, PCR amplifications were set up in a reaction volume of 25 µL that contained 5 µL of extracted sample or negative control (sterile double-distilled H 2 O) or plasmid. Thermal cycling was as follows: 50
• C for 2 min, an initial denaturation step at 95
• C for 10 min that was followed by 45 cycles at 95
• C for 15 s (denaturation) and 60
• C for 1 min (reannealing and extension). Standard curves for the quantification of DNA were constructed by plotting the threshold cycle against the logarithm of serial 10-fold dilutions, ranging from 10 2 to 10 5 , of the corresponding plasmid. Amplification data were analysed by the Sequence Detection System software (Applied Biosystems). Each sample was subjected to simultaneous TaqMan PCR for the housekeeping gene human β-globin; results were considered acceptable only in the presence of β-globin 
Statistical analysis
Operating characteristics, including sensitivity, specificity, negative predictive value (NPV), positive predictive value (PPV) and receiver operating characteristic (ROC) curve analysis, were evaluated by using commercially available software (MedCalc; version 9.2.1.0). Table 1 7 copies/mL in relation to a diagnosis of BKVAN, the following operating characteristics were evidenced: sensitivity, 100%; specificity, 95.5%, NPV, 100% and PPV, 27.3%. Operating characteristics for all the cut-off values are reported in Table 1 . Regarding the temporal profile, usually viruria preceded BK viraemia by 1.5 months (mean ± standard deviation, 42.1 ± 30.1 days), although levels <10 5 copies/mL could also be detected in the absence of subsequent detection of viraemia, while viraemia never occurred in the absence of viruria.
Results
Results are summarized in
Considering healthy controls, BKV DNA was positive in 4/30 (13.3%; viral load >10 4 copies/mL but <1.3 × 10 4 copies/mL in all of them) and in 5/30 (16.7%; viral load <10 7 in all of them) of serum and urine samples, respectively; considering non-transplant patients with lupus nephritis, BKV DNA was positive in 3/50 (6.0%; viral load >10 4 copies/mL but <1.3 × 10 4 copies/mL in one) and in 20/50 (40.0%; viral load <10 7 in all of them) in serum and urine samples, respectively.
